×
About 4,404 results

ALLMedicine™ Stevens-Johnson Syndrome Center

Research & Reviews  1,887 results

A Systematic Review of Efficacy and Safety of Monotherapy and Combination Therapy With ...
https://doi.org/10.1177/1203475421993779
Journal of Cutaneous Medicine and Surgery; Sachdeva M, Maliyar K et. al.

Feb 26th, 2021 - Biologic drugs have the potential to halt the progression of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) by decreasing concentrations of tumor necrosis factor-α, a cytokine implicated in epithelial cell death. The objective...

Effect of older age on complications and mortality of inpatients with Stevens-Johnson S...
https://doi.org/10.1016/j.jaad.2021.02.046
Journal of the American Academy of Dermatology; Patel S, Cadwell JB et. al.

Feb 23rd, 2021 - Effect of older age on complications and mortality of inpatients with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.|2021|Patel S,Cadwell JB,Lambert WC,|

Human leukocyte antigen class I and II genes associated with dipyrone-related Stevens-J...
https://doi.org/10.1016/j.jtos.2021.02.008
The Ocular Surface; Wakamatsu TH, Ueta M et. al.

Feb 22nd, 2021 - Human leukocyte antigen class I and II genes associated with dipyrone-related Stevens-Johnson syndrome and severe ocular complications in a Brazilian population.|2021|Wakamatsu TH,Ueta M,Inoue C,Costa KA,Sakano LY,|

Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/otera...
https://doi.org/10.1684/ejd.2020.3957
European Journal of Dermatology : EJD; Komatsu-Fujii T, Ogawa M et. al.

Feb 15th, 2021 - Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.|2021|Komatsu-Fujii T,Ogawa M,Nonoyama S,Fukumoto T,Tanabe H,|

The Role of IL-13, IL-15 and Granulysin in the Pathogenesis of Stevens-Johnson Syndrome...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876748
Clinical and Applied Thrombosis/hemostasis : Official Jou... Sadek M, Iqbal O et. al.

Feb 9th, 2021 - Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are Severe Cutaneous Adverse Reactions (SCARS) characterized by fever and mucocutaneous lesions leading to necrosis and sloughing of the epidermis. Conjunctival lesions are report...

see more →

Guidelines  7 results

Society of Dermatology Hospitalists supportive care guidelines for the management of St...
https://doi.org/10.1016/j.jaad.2020.02.066
Journal of the American Academy of Dermatology; Seminario-Vidal L, Kroshinsky D et. al.

Mar 10th, 2020 - Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening conditions with high morbidity and mortality. Supportive care management of SJS/TEN is highly variable. A systematic review of the literature was performed by...

Outpatient management and follow-up recommendations for adverse drug reactions: guideli...
https://www.ncbi.nlm.nih.gov/pubmed/31233575
Cutis Khanna R, Vaudreuil A et. al.

Jun 24th, 2019 - Acute generalized exanthematous pustulosis (AGEP), drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, and Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) are types of adverse drug reactions (ADRs), each with their ...

British Association of Dermatologists' guidelines for the management of Stevens-Johnson...
https://doi.org/10.1111/bjd.17841
The British Journal of Dermatology; McPherson T, Exton LS et. al.

Mar 4th, 2019 - British Association of Dermatologists' guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018.|2019|McPherson T,Exton LS,Biswas S,Creamer D,Dziewulski P,|methods,standards,standards,...

U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolys...
https://doi.org/10.1111/bjd.14530
The British Journal of Dermatology; Creamer D, Walsh SA et. al.

Jun 18th, 2016 - U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.|2016|Creamer D,Walsh SA,Dziewulski P,Exton LS,Lee HY,|therapeutic use,methods,therapeutic use,therapy,therapy,methods,therapeutic use,therapy...

Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B gen...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206662
Clinical Pharmacology and Therapeutics; Caudle KE, Rettie AE et. al.

Aug 7th, 2014 - Phenytoin is a widely used antiepileptic drug with a narrow therapeutic index and large interpatient variability, partly due to genetic variations in the gene encoding cytochrome P450 (CYP)2C9 (CYP2C9). Furthermore, the variant allele HLA-B*15:02,...

see more →

Drugs  217 results see all →

Clinicaltrials.gov  2,171 results

A Systematic Review of Efficacy and Safety of Monotherapy and Combination Therapy With ...
https://doi.org/10.1177/1203475421993779
Journal of Cutaneous Medicine and Surgery; Sachdeva M, Maliyar K et. al.

Feb 26th, 2021 - Biologic drugs have the potential to halt the progression of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) by decreasing concentrations of tumor necrosis factor-α, a cytokine implicated in epithelial cell death. The objective...

Effect of older age on complications and mortality of inpatients with Stevens-Johnson S...
https://doi.org/10.1016/j.jaad.2021.02.046
Journal of the American Academy of Dermatology; Patel S, Cadwell JB et. al.

Feb 23rd, 2021 - Effect of older age on complications and mortality of inpatients with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.|2021|Patel S,Cadwell JB,Lambert WC,|

Human leukocyte antigen class I and II genes associated with dipyrone-related Stevens-J...
https://doi.org/10.1016/j.jtos.2021.02.008
The Ocular Surface; Wakamatsu TH, Ueta M et. al.

Feb 22nd, 2021 - Human leukocyte antigen class I and II genes associated with dipyrone-related Stevens-Johnson syndrome and severe ocular complications in a Brazilian population.|2021|Wakamatsu TH,Ueta M,Inoue C,Costa KA,Sakano LY,|

Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/otera...
https://doi.org/10.1684/ejd.2020.3957
European Journal of Dermatology : EJD; Komatsu-Fujii T, Ogawa M et. al.

Feb 15th, 2021 - Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.|2021|Komatsu-Fujii T,Ogawa M,Nonoyama S,Fukumoto T,Tanabe H,|

Dexamethasone - dexamethasone tablet-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c602bb8-33d0-7839-e053-2a91aa0aabf5

Feb 11th, 2021 - Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis and serum s...

see more →

News  109 results

How to distinguish Stevens-Johnson syndrome from its mimickers
https://www.mdedge.com/dermatology/article/207882/medical-dermatology/how-distinguish-stevens-johnson-syndrome-its?channel=39313
Kari Oakes

Sep 10th, 2019 - NEW YORK – Inpatient dermatology consults can make all the difference when a serious dermatology complication is suspected, said Lucia Seminario-Vidal, MD, PhD, speaking at a hospital dermatology–focused session of the summer meeting of the Americ.

Peeling skin with chills
https://www.mdedge.com/familymedicine/article/205843/dermatology/peeling-skin-chills?channel=114
MDedge Family Medicine;

Aug 8th, 2019 - The physician thought that this was most likely toxic epidermal necrolysis (TEN). He was in a small hospital without a burn unit, so he drew baseline labs and blood cultures, and started to give intravenous fluids to treat the dehydration.

Asboe-Hansen Sign in Toxic Epidermal Necrolysis
https://www.mdedge.com/dermatology/article/198731/rare-diseases/asboe-hansen-sign-toxic-epidermal-necrolysis?channel=285
Jessica R. Dowling, BA, Kathryn L. Anderson, MD et. al.

Apr 11th, 2019 - To the Editor: A 25-year-old woman with no notable medical history was admitted to the hospital for suspected Stevens-Johnson syndrome (SJS). The patient was started on amoxicillin 7 days prior to the skin eruption for prophylaxis before removal o.

Fingernail Abnormalities After a Systemic Illness
https://www.mdedge.com/fedprac/article/198429/trauma/fingernail-abnormalities-after-systemic-illness/page/0/2?channel=58390

Apr 8th, 2019 - Conclusion Although Stevens-Johnson syndrome is a rare cause of onychomadesis, and the pathophysiology of this sequela is poorly understood, this case illustrates a common nail abnormality with multiple potential etiologies that are discerned by a.

Study identifies potential biomarkers for an increased risk of SCARs-related mortality
https://www.mdedge.com/dermatology/article/189345/medical-dermatology/study-identifies-potential-biomarkers-increased-risk
Bianca Nogrady

Nov 21st, 2018 - Researchers have identified biomarkers that might eventually be used to flag cancer patients with severe cutaneous adverse reactions (SCARs) at an increased risk of mortality. In a retrospective study, elevated elafin, interleukin (IL)-6, and tumo.

see more →

Patient Education  13 results see all →